97 related articles for article (PubMed ID: 16289975)
1. Targeted therapy in colorectal cancer: do we know enough?
Pantaleo MA; Palassini E; Labianca R; Biasco G
Dig Liver Dis; 2006 Feb; 38(2):71-7. PubMed ID: 16289975
[TBL] [Abstract][Full Text] [Related]
2. Perspectives in colorectal cancer - Sixth Annual Conference. Metastatic colorectal cancer.
Morse MA
IDrugs; 2005 Dec; 8(12):974-7. PubMed ID: 16320126
[No Abstract] [Full Text] [Related]
3. First-line treatment of patients with metastatic colorectal cancer: an overview of recent data on chemotherapy plus targeted agents.
Cercek A; Saltz LB
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S47-51. PubMed ID: 19064406
[TBL] [Abstract][Full Text] [Related]
4. Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: the role of anti-VEGF and anti-EGFR antibodies.
Geva R; Prenen H; Topal B; Aerts R; Vannoote J; Van Cutsem E
J Surg Oncol; 2010 Dec; 102(8):937-45. PubMed ID: 21165996
[TBL] [Abstract][Full Text] [Related]
5. [Some problems facing the molecular targeting therapy for colorectal cancer].
Xu JM
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):321-3. PubMed ID: 19799077
[No Abstract] [Full Text] [Related]
6. Molecular mechanisms and targeting of colorectal cancer.
Vanhoefer U
Semin Oncol; 2005 Dec; 32(6 Suppl 8):7-10. PubMed ID: 16360005
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy in colorectal cancer.
Rajpal S; Venook AP
Clin Adv Hematol Oncol; 2006 Feb; 4(2):124-32. PubMed ID: 16728921
[TBL] [Abstract][Full Text] [Related]
8. Current issues in the targeted therapy of advanced colorectal cancer.
Knijn N; Tol J; Punt CJ
Discov Med; 2010 Apr; 9(47):328-36. PubMed ID: 20423677
[TBL] [Abstract][Full Text] [Related]
9. Antivascular endothelial growth factor monoclonal antibody therapy: a promising paradigm in colorectal cancer.
Franson PJ; Lapka DV
Clin J Oncol Nurs; 2005 Feb; 9(1):55-60. PubMed ID: 15751499
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies: the foundation of therapy for colorectal cancer in the 21st century?
Hoff PM; Ellis LM; Abbruzzese JL
Oncology (Williston Park); 2004 May; 18(6):736-41; discussion 742, 745-6. PubMed ID: 15214593
[TBL] [Abstract][Full Text] [Related]
11. Future directions in the use of antiangiogenic agents in patients with colorectal cancer.
Hoff PM
Semin Oncol; 2004 Dec; 31(6 Suppl 17):17-21. PubMed ID: 15696026
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies in the treatment of colorectal cancer.
Veronese ML; O'Dwyer PJ
Eur J Cancer; 2004 Jun; 40(9):1292-301. PubMed ID: 15177487
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis inhibition in the treatment of colorectal cancer Part 3 of a 3-part series: targeting VEGF--current and future research directions.
Goldberg RM; Hurwitz HI; Fuchs CS
Clin Adv Hematol Oncol; 2005 Dec; 3(12):1-10; quiz 11. PubMed ID: 16555433
[TBL] [Abstract][Full Text] [Related]
14. Systemic therapy for advanced or metastatic colorectal cancer: National Comprehensive Cancer Network guidelines for combining anti-vascular endothelial growth factor and anti-epidermal growth factor receptor monoclonal antibodies with chemotherapy.
Engstrom PF;
Pharmacotherapy; 2008 Nov; 28(11 Pt 2):18S-22S. PubMed ID: 18980548
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy for colorectal cancer.
Hwang J; Marshall JL
Curr Opin Investig Drugs; 2006 Dec; 7(12):1062-6. PubMed ID: 17209523
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies in gastrointestinal cancers.
Bronte G; Cicero G; Cusenza S; Galvano A; Musso E; Rizzo S; Sortino G; Roselli M; Bazan V; Fiorentino E; Russo A
Expert Opin Biol Ther; 2013 Jun; 13(6):889-900. PubMed ID: 23441760
[TBL] [Abstract][Full Text] [Related]
17. Biologic therapy for colon cancer.
He AR; Marshall J
Clin Adv Hematol Oncol; 2005 Jul; 3(7):555-61. PubMed ID: 16167038
[TBL] [Abstract][Full Text] [Related]
18. Targeted treatments in colorectal cancer: state of the art and future perspectives.
Arnold D; Seufferlein T
Gut; 2010 Jun; 59(6):838-58. PubMed ID: 20551469
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapies in solid tumours: results and promises.
Pantaleo MA; Saponara M; Nannini M; Biasco G
Minerva Med; 2007 Oct; 98(5):603-23. PubMed ID: 18043567
[TBL] [Abstract][Full Text] [Related]
20. Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: an Acta Oncologica expert report.
Nygren P; Sørbye H; Osterlund P; Pfeiffer P
Acta Oncol; 2005; 44(3):203-17. PubMed ID: 16076691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
